These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 20401423

  • 1. Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons.
    Yan JJ, Chow AL, Leung CH, Sun RW, Ma DL, Che CM.
    Chem Commun (Camb); 2010 Jun 14; 46(22):3893-5. PubMed ID: 20401423
    [Abstract] [Full Text] [Related]

  • 2. Metal/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs.
    Cisnetti F, Gautier A.
    Angew Chem Int Ed Engl; 2013 Nov 11; 52(46):11976-8. PubMed ID: 24115500
    [No Abstract] [Full Text] [Related]

  • 3. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes.
    Ray S, Mohan R, Singh JK, Samantaray MK, Shaikh MM, Panda D, Ghosh P.
    J Am Chem Soc; 2007 Dec 05; 129(48):15042-53. PubMed ID: 17988129
    [Abstract] [Full Text] [Related]

  • 4. N-Heterocyclic carbene metal complexes in medicinal chemistry.
    Oehninger L, Rubbiani R, Ott I.
    Dalton Trans; 2013 Mar 14; 42(10):3269-84. PubMed ID: 23223752
    [Abstract] [Full Text] [Related]

  • 5. Beyond catalysis: N-heterocyclic carbene complexes as components for medicinal, luminescent, and functional materials applications.
    Mercs L, Albrecht M.
    Chem Soc Rev; 2010 Jun 14; 39(6):1903-12. PubMed ID: 20502793
    [Abstract] [Full Text] [Related]

  • 6. Syntheses, crystal structures, reactivity, and photochemistry of gold(III) bromides bearing N-heterocyclic carbenes.
    Hirtenlehner C, Krims C, Hölbling J, List M, Zabel M, Fleck M, Berger RJ, Schoefberger W, Monkowius U.
    Dalton Trans; 2011 Oct 14; 40(38):9899-910. PubMed ID: 21879094
    [Abstract] [Full Text] [Related]

  • 7. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA, Patil SA, Patil R, Keri RS, Budagumpi S, Balakrishna GR, Tacke M.
    Future Med Chem; 2015 Oct 14; 7(10):1305-33. PubMed ID: 26144266
    [Abstract] [Full Text] [Related]

  • 8. Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents.
    Zou T, Lum CT, Chui SS, Che CM.
    Angew Chem Int Ed Engl; 2013 Mar 04; 52(10):2930-3. PubMed ID: 23371740
    [No Abstract] [Full Text] [Related]

  • 9. Gold(III) N-heterocyclic carbene complexes mediated synthesis of β-enaminones from 1,3-dicarbonyl compounds and aliphatic amines.
    Samantaray MK, Dash C, Shaikh MM, Pang K, Butcher RJ, Ghosh P.
    Inorg Chem; 2011 Mar 07; 50(5):1840-8. PubMed ID: 21254751
    [Abstract] [Full Text] [Related]

  • 10. Advances in metal-carbene complexes as potent anti-cancer agents.
    Gautier A, Cisnetti F.
    Metallomics; 2012 Jan 07; 4(1):23-32. PubMed ID: 22027962
    [Abstract] [Full Text] [Related]

  • 11. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
    Meyer A, Oehninger L, Geldmacher Y, Alborzinia H, Wölfl S, Sheldrick WS, Ott I.
    ChemMedChem; 2014 Aug 07; 9(8):1794-800. PubMed ID: 24803348
    [Abstract] [Full Text] [Related]

  • 12. Cationic gold(I) heteroleptic complexes bearing a pyrazole-derived N-heterocyclic carbene: syntheses, characterizations, and cytotoxic activities.
    Sivaram H, Tan J, Huynh HV.
    Dalton Trans; 2013 Sep 14; 42(34):12421-8. PubMed ID: 23860905
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, isolation and characterization of cationic gold(I) N-heterocyclic carbene (NHC) complexes.
    de Frémont P, Stevens ED, Fructos MR, Mar Díaz-Requejo M, Pérez PJ, Nolan SP.
    Chem Commun (Camb); 2006 May 21; (19):2045-7. PubMed ID: 16767270
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.
    Rubbiani R, Salassa L, de Almeida A, Casini A, Ott I.
    ChemMedChem; 2014 Jun 21; 9(6):1205-10. PubMed ID: 24677779
    [Abstract] [Full Text] [Related]

  • 15. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
    Messori L, Marchetti L, Massai L, Scaletti F, Guerri A, Landini I, Nobili S, Perrone G, Mini E, Leoni P, Pasquali M, Gabbiani C.
    Inorg Chem; 2014 Mar 03; 53(5):2396-403. PubMed ID: 24547701
    [Abstract] [Full Text] [Related]

  • 16. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW, Li CK, Ma DL, Yan JJ, Lok CN, Leung CH, Zhu N, Che CM.
    Chemistry; 2010 Mar 08; 16(10):3097-113. PubMed ID: 20162647
    [Abstract] [Full Text] [Related]

  • 17. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W, Gust R.
    Chem Soc Rev; 2013 Jan 21; 42(2):755-73. PubMed ID: 23147001
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle.
    Castelli S, Vassallo O, Katkar P, Che CM, Sun RW, Desideri A.
    Arch Biochem Biophys; 2011 Dec 15; 516(2):108-12. PubMed ID: 22033340
    [Abstract] [Full Text] [Related]

  • 19. Ligand-controlled highly regioselective and asymmetric hydrogenation of quinoxalines catalyzed by ruthenium N-heterocyclic carbene complexes.
    Urban S, Ortega N, Glorius F.
    Angew Chem Int Ed Engl; 2011 Apr 11; 50(16):3803-6. PubMed ID: 21442699
    [No Abstract] [Full Text] [Related]

  • 20. One-step formation of cyclometallated Au(III) N,S-heterocyclic carbene: crystallographic analysis.
    Han X, Koh LL, Weng Z, Hor TS.
    Dalton Trans; 2009 Sep 21; (35):7248-52. PubMed ID: 20449169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.